يعرض 1 - 5 نتائج من 5 نتيجة بحث عن '"CD6 antigen"', وقت الاستعلام: 1.51s تنقيح النتائج
  1. 1
  2. 2
    دورية أكاديمية

    المصدر: Arteriosclerosis, thrombosis, and vascular biology 38(9), 2225-2235 (2018). doi:10.1161/ATVBAHA.118.311023

    جغرافية الموضوع: DE

    العلاقة: info:eu-repo/semantics/altIdentifier/issn/1079-5642; info:eu-repo/semantics/altIdentifier/issn/1524-4636; info:eu-repo/semantics/altIdentifier/issn/2330-9180; info:eu-repo/semantics/altIdentifier/pmid/pmid:29976769; info:eu-repo/semantics/altIdentifier/issn/2330-9199; info:eu-repo/semantics/altIdentifier/issn/0276-5047; info:eu-repo/semantics/altIdentifier/issn/1049-8834; https://pub.dzne.de/record/140155Test; https://pub.dzne.de/search?p=id:%22DZNE-2020-06477%22Test

  3. 3

    المصدر: Arteriosclerosis, thrombosis, and vascular biology 38(9), 2225-2235 (2018). doi:10.1161/ATVBAHA.118.311023

  4. 4
    مورد إلكتروني

    مصطلحات الفهرس: insulin dependent diabetes mellitus, macrophage, male, mouse, nonhuman, podocyte, priority journal, renal protection, signal transduction, systolic blood pressure, albumin/ec [Endogenous Compound], apoptosis signal regulating kinase 1/ec [Endogenous Compound], CD6 antigen/ec [Endogenous Compound], collagen type 4/ec [Endogenous Compound], cystatin C/ec [Endogenous Compound], endothelial nitric oxide synthase/ec [Endogenous Compound], fibronectin/ec [Endogenous Compound], glucose/ec [Endogenous Compound], hemoglobin A1c/ec [Endogenous Compound], kidney injury molecule 1/ec [Endogenous Compound], messenger RNA/ec [Endogenous Compound], mitogen activated protein kinase p38/ec [Endogenous Compound], monocyte chemotactic protein 1/ec [Endogenous Compound], plasminogen activator inhibitor 1/ec [Endogenous Compound], protein serine threonine kinase inhibitor/dt [Drug Therapy], protein serine threonine kinase inhibitor/po [Oral Drug Administration], protein serine threonine kinase inhibitor/pd [Pharmacology], RNA/ec [Endogenous Compound], streptozocin, transforming growth factor beta1/ec [Endogenous Compound], unclassified drug, urinary tract agent/dt [Drug Therapy], urinary tract agent/po [Oral Drug Administration], urinary tract agent/pd [Pharmacology], WT1 protein/ec [Endogenous Compound], gs 444217/dt [Drug Therapy], gs 444217/po [Oral Drug Administration], gs 444217/pd [Pharmacology], albuminuria, animal cell, animal experiment, animal model, animal tissue, article, cell loss, controlled study, diabetic nephropathy/dt [Drug Therapy], disease course, early intervention, enzyme inhibition, glomerulosclerosis, glucose blood level, hypertension, IC50, in vitro study, Article

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/41052Test
    Diabetes
    Click here for full text options
    LibKey Link

  5. 5
    مورد إلكتروني

    مصطلحات الفهرس: insulin dependent diabetes mellitus, macrophage, male, mouse, nonhuman, podocyte, priority journal, renal protection, signal transduction, systolic blood pressure, albumin/ec [Endogenous Compound], apoptosis signal regulating kinase 1/ec [Endogenous Compound], CD6 antigen/ec [Endogenous Compound], collagen type 4/ec [Endogenous Compound], cystatin C/ec [Endogenous Compound], endothelial nitric oxide synthase/ec [Endogenous Compound], fibronectin/ec [Endogenous Compound], glucose/ec [Endogenous Compound], hemoglobin A1c/ec [Endogenous Compound], kidney injury molecule 1/ec [Endogenous Compound], messenger RNA/ec [Endogenous Compound], mitogen activated protein kinase p38/ec [Endogenous Compound], monocyte chemotactic protein 1/ec [Endogenous Compound], plasminogen activator inhibitor 1/ec [Endogenous Compound], protein serine threonine kinase inhibitor/dt [Drug Therapy], protein serine threonine kinase inhibitor/po [Oral Drug Administration], protein serine threonine kinase inhibitor/pd [Pharmacology], RNA/ec [Endogenous Compound], streptozocin, transforming growth factor beta1/ec [Endogenous Compound], unclassified drug, urinary tract agent/dt [Drug Therapy], urinary tract agent/po [Oral Drug Administration], urinary tract agent/pd [Pharmacology], WT1 protein/ec [Endogenous Compound], gs 444217/dt [Drug Therapy], gs 444217/po [Oral Drug Administration], gs 444217/pd [Pharmacology], albuminuria, animal cell, animal experiment, animal model, animal tissue, article, cell loss, controlled study, diabetic nephropathy/dt [Drug Therapy], disease course, early intervention, enzyme inhibition, glomerulosclerosis, glucose blood level, hypertension, IC50, in vitro study, Article